These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 12545882)

  • 41. Gene therapy and erectile dysfunction: the current status.
    Lau DH; Kommu SS; Siddiqui EJ; Thompson CS; Morgan RJ; Mikhailidis DP; Mumtaz FH
    Asian J Androl; 2007 Jan; 9(1):8-15. PubMed ID: 16888683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection.
    Musicki B; Palese MA; Crone JK; Burnett AL
    Biol Reprod; 2004 Feb; 70(2):282-9. PubMed ID: 14522830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction.
    Francis SH; Corbin JD
    Urol Clin North Am; 2005 Nov; 32(4):419-29, vi. PubMed ID: 16291034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
    Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
    Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypogonadism and erectile dysfunction: the role for testosterone therapy.
    Shabsigh R
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S9-13. PubMed ID: 12934045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats.
    Ushiyama M; Kuramochi T; Katayama S
    Hypertens Res; 2006 Jul; 29(7):523-32. PubMed ID: 17044665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term oral treatment with BAY 41-2272 ameliorates impaired corpus cavernosum relaxations in a nitric oxide-deficient rat model.
    Claudino MA; da Silva FH; Mónica FZ; Rojas-Moscoso JA; De Nucci G; Antunes E
    BJU Int; 2011 Jul; 108(1):116-22. PubMed ID: 20950311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment.
    Seftel AD
    J Urol; 2003 Jun; 169(6):1999-2007. PubMed ID: 12771705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiology of penile erection and pathophysiology of erectile dysfunction.
    Dean RC; Lue TF
    Urol Clin North Am; 2005 Nov; 32(4):379-95, v. PubMed ID: 16291031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of penile fibrosis model in a rat using mouse NIH 3T3 fibroblasts expressing transforming growth factor beta1.
    Ryu JK; Song SU; Han JY; Chu YC; Lee M; Kim JS; Kim SJ; Suh JK
    Biol Reprod; 2005 Apr; 72(4):916-21. PubMed ID: 15601922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions.
    Uckert S; Becker AJ; Ness BO; Stief CG; Scheller F; Knapp WH; Jonas U
    World J Urol; 2003 May; 20(6):323-6. PubMed ID: 12811490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel therapeutic targets for erectile dysfunction.
    Williams SK; Melman A
    Maturitas; 2012 Jan; 71(1):20-7. PubMed ID: 22154078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
    Kim NN
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
    Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
    Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential application of gene therapy for the treatment of erectile dysfunction.
    Bivalacqua TJ; Hellstrom WJ
    J Androl; 2001; 22(2):183-90. PubMed ID: 11229791
    [No Abstract]   [Full Text] [Related]  

  • 57. Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment.
    Hatzichristou DG; Hatzimouratidis K; Tzortzis V; Apostolidis A; Bekos A; Ioannidis E
    Int J Impot Res; 2003 Apr; 15(2):99-104. PubMed ID: 12789388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weapons of penile smooth muscle destruction: androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum.
    Traish AM; Kim N
    Aging Male; 2005; 8(3-4):141-6. PubMed ID: 16390736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part I-theoretical study and mathematical modeling.
    Ng WK; Ng EY; Chia SJ
    Int J Impot Res; 2008; 20(3):295-306. PubMed ID: 18075507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human neural crest stem cells transplanted in rat penile corpus cavernosum to repair erectile dysfunction.
    Song YS; Lee HJ; Park IH; Lim IS; Ku JH; Kim SU
    BJU Int; 2008 Jul; 102(2):220-4; discussion 224. PubMed ID: 18284412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.